Steingo, Brian
Al Malik, Yaser
Bass, Ann D.
Berkovich, Regina
Carraro, Matthew
Fernández, Óscar
Ionete, Carolina
Massacesi, Luca
Meuth, Sven G.
Mitsikostas, Dimos D.
Pardo, Gabriel
Simm, Renata Faria
Traboulsee, Anthony
Choudhry, Zia
Daizadeh, Nadia
Compston, D. Alastair S.
,
Funding for this research was provided by:
Sanofi
Bayer Healthcare Pharmaceuticals
Article History
Received: 6 March 2020
Revised: 4 June 2020
Accepted: 6 June 2020
First Online: 24 June 2020
Compliance with ethical standards
:
: BS reports receiving consulting and speaking fees and/or grant/research support from Alexion, Biogen, EMD Serono, Genentech, Novartis, Sanofi, and Teva. YAM reports receiving compensation for advisory board participation and conference travel from Genzyme, Merck, and Roche. ADB reports receiving research funding, compensation for medical advisory boards, and compensation for speakers bureaus from Actelion, Biogen, EMD Serono, Genentech-Roche, Mallinckrodt, Novartis, Sanofi, and TG Therapeutics. RB reports receiving compensation for advisory board participation and consulting from Acorda, Avanir, Bayer, Biogen, Novartis, Questcor, Sanofi, and Teva. MC reports receiving speaking and consulting fees, and advisory honoraria from Biogen, Genentech, Genzyme, and Mallinckrodt. OF reports receiving speaking and/or consulting fees from Allergan, Almirall, Bayer Schering, Biogen, Merck Serono, Novartis, Sanofi, and Teva; compensation for serving as a journal editor, associate editor, or member of an editorial advisory board from <i>Revista Española de Esclerosis Múltiple</i>; and research support from Hospital Foundation FIMABIS. CI reports receiving compensation for advisory board participation from Sanofi and research support from Biogen, Roche, and Sanofi. LM reports receiving consulting and/or speaking fees, and research grants or conference travel sponsorship from Biogen, Merck Serono, Mylan, Novartis, Roche, and Sanofi. SGM reports receiving honoraria for lecturing, travel expenses for attending meetings, and financial research support from Almirall, Amicus Therapeutics Germany, Bayer, Biogen, Celgene, Chugai Pharma, Diamed, Genzyme, MedDay Pharmaceuticals, Merck Serono, Novartis, Novo Nordisk, Ono Pharma, Quintiles-IMS, Roche, Sanofi Aventis, and Teva. DDM reports receiving speaking and/or consulting fees from Allergan, Amgen, Bayer, CEFALY, Eli Lilly, electroCore, Genesis Pharma, Merz, Mylan, Novartis, Roche, Sanofi Genzyme, and Teva, and grant research support from Biogen and Sanofi Genzyme. GP reports receiving compensation for consulting and/or speaker bureau from Alexion, Biogen, Celgene, EMD Serono, Novartis, Roche Genentech, Sanofi Genzyme, and Teva. RFS reports receiving consulting fees and compensation for advisory board participation from Biogen and Sanofi, and lecture fees from Biogen, Merck, Novartis, and Roche. AT reports receiving consulting and/or speaking fees and grant/research support from Biogen, Chugai, Roche, Sanofi, and Teva. ZC and ND receive compensation as employees of Sanofi. DASC reports receiving consulting fees and grant support from Genzyme and lecture fees from Bayer Schering, on behalf of the University of Cambridge; and personal remuneration for lecture fees from Genzyme from July 2014.
: All patients provided written informed consent. The studies were conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. All procedures were approved by local institutional ethics review boards of participating sites.